Figure 3.

Virological rebound during the first year of antiretroviral therapy. Figure 3 represents virological rebound stratified by WHO clinical stage (A), cART regimen (B) and cotrimoxazole preventive therapy (CPT) status (C). Stage 1–4 represent WHO clinical staging; ABC–abacavir; AZT—zidovudine; TDF—tenofovir; No. at risk—Number at risk.